Dr. John Lynam is a highly respected urologist and the newest addition at AUI’s Leesburg and Oxford offices. Learn more about Dr. Lynam here.
Continue readingDr. John Lynam: A Beacon of Success in Urology
Dr. Rolando Rivera of Advanced Urology Institute Re-designated as a UroLift Center of Excellence
Dr. Rolando Rivera of Advanced Urology Institute Re-designated as a UroLift Center of Excellence
About Dr. Rolando Rivera
Rolando Rivera, MD, FACS is an established Urologist in Naples, Florida, who features over two decades of experience in his field. Dr. Rivera’s acclaimed career in medicine began in 1996, when he graduated from the University of Puerto Rico School of Medicine in San Juan. Upon earning his Medical Degree, he completed an internship at Brooke Army Medical Center in San Antonio, Texas, before undertaking his residency at the University of Florida Shands Medical Center in Gainesville. Pursuing advanced medical training, Dr. Rivera then completed a fellowship in Female Urology, Pelvic Surgery and Urodynamics at the University of Miami.
About Advanced Urology Institute
As one of the largest full-service urology groups Florida, our 37 locations offer comprehensive urology services, from evaluation and pre-surgical preparation, to surgery and rehabilitation. We have evaluated numerous patients and performed thousands of urologic surgical and cancer procedures in the last decade with excellent outcomes. We are dedicated to combining clinical excellence, advanced technology, and patient- and family-centered care.
For more information contact AUI at: 855-977-4888
Congratulations to Dr. Jonathan Jay for being selected as Top Doctor in 2021 for Naples Illustrated Magazine
Congratulations to Dr. Jonathan Jay for being selected as Top Doctor in 2021 for Naples Illustrated Magazine
About Dr. Jonathan Jay
Dr. Jay received his Bachelor of Science degree in Physiology from Michigan State University, graduating with Honors. He went on to complete his medical education at the University of Michigan, Ann Arbor. He completed his residency training at Henry Ford Hospital before entering and completing his fellowship training at Beth Israel Deaconess Medical Center, Harvard Medical School in Boston. He received numerous honors and awards throughout his training, including Outstanding Resident Training Award and Lansing School District Distinguished Alumni Award.
He has made national presentations on various urological topics and has published multiple scientific papers in peer-reviewed journals as well as book chapters. He is involved in clinical research, including clinical trials for the minimally invasive correction of bladder control problems.
About Advanced Urology Institute
As one of the largest full-service urology groups Florida, our 37 locations offer comprehensive urology services, from evaluation and pre-surgical preparation, to surgery and rehabilitation. We have evaluated numerous patients and performed thousands of urologic surgical and cancer procedures in the last decade with excellent outcomes. We are dedicated to combining clinical excellence, advanced technology, and patient- and family-centered care.
For more information contact AUI at: 855-977-4888
Janelle Bunce, PA-C of Advanced Urology Institute Re-designated as a UroLift Center of Excellence
Congratulations to Janelle Bunce, PA-C on having been re-designated as a UroLift Center of Excellence in May 2021.
About Janelle Bunce, PA-C
Janelle Bunce PA-C is a nationally certified Physician Assistant who earned her Masters of Medical Science and Physician Assistant studies degrees at Nova Southeastern a University in Davie, FL in 2004. She is a member of the American Academy of Physician Assistants, Florida Urological Society and the American Urological Association. She has participated in multiple medical mission trips. Her specialties include adult and pediatric urology. She is currently a practicing physician assistant in Naples, FL.
About Advanced Urology Institute
As one of the largest full-service urology groups Florida, our 37 locations offer comprehensive urology services, from evaluation and pre-surgical preparation, to surgery and rehabilitation. We have evaluated numerous patients and performed thousands of urologic surgical and cancer procedures in the last decade with excellent outcomes. We are dedicated to combining clinical excellence, advanced technology, and patient- and family-centered care.
For more information contact AUI at: 855-977-4888
Dr. Jonathan Jay selected as the Top Urologist in Florida in May 2021 by Top Doctor Magazine
Congratulations to Dr. Jonathan Jay on having been selected as the top urologist in Florida in May 2021 by Top Doctor Magazine
Congratulations to Dr. Rolando Rivera for being selected as Top Doctor in April 2021 for Naples Illustrated
Congratulations to Dr. Rolando Rivera for being selected as Top Doctor in April 2021 for Naples Illustrated.
˙
Dr. Rivera also had an article titled Advanced Treatment for Overactive Bladder, published in Health & Wellness Magazine in April 2021.
Dr. Amar J. Raval of Advanced Urology Institute Recognized as an Axonics® Center of Excellence
Dr. Amar J. Raval is an expert at treating bladder and bowel dysfunction with innovative Axonics Therapy.
June 28, 2021
Advanced Urology Institute (AUI) has been designated an Axonics Center of Excellence by Axonics Modulation Technologies, Inc. The designation recognizes the AUI team and specifically Dr. Amar J. Raval for his expertise with Axonics Therapy and sincere commitment to changing the lives of patients suffering from bladder and bowel dysfunction.
Today, millions of Americans suffer from overactive bladder and fecal incontinence.1 Patients in the New Port Richey and Tampa, Florida areas with chronic and debilitating symptoms related to bladder and bowel dysfunction may seek treatment from the experts at AUI. Axonics Therapy gently stimulates the sacral nerve (sacral neuromodulation), restoring normal communication between the brain and the bladder. Axonics Therapy has been clinically proven to provide rapid and long-lasting relief of symptoms associated with bladder and bowel dysfunction.
In a clinical study, 129 patients with urgency incontinence were treated with Axonics Therapy. At 2-years, 93% of patients had successful therapy and 94% of patients were satisfied with their therapy.2
The Axonics Center of Excellence program recognizes highly trained and experienced physicians (typically urologists, urogynecologists, and colorectal surgeons) and clinical practices that are committed to patient education and providing exemplary care to achieve optimal clinical outcomes and patient satisfaction.
“AUI is proud to be recognized as a Center of Excellence. This designation is a testament to the dedication of our entire team, and in particular to Dr. Amar J. Raval,” said Erica Williams, Chief Administrative Officer. “We are committed to providing the best care to our patients and are extremely pleased to offer Axonics Therapy.”
About Advanced Urology Institute
As one of the largest full-service urology groups Florida, our 37 locations offer comprehensive urology services, from evaluation and pre-surgical preparation, to surgery and rehabilitation. We have evaluated numerous patients and performed thousands of urologic surgical and cancer procedures in the last decade with excellent outcomes. We are dedicated to combining clinical excellence, advanced technology, and patient- and family-centered care.
For more information contact AUI at: 855-977-4888
About Axonics Modulation Technologies, Inc. and Sacral Neuromodulation
Axonics, based in Irvine, Calif., has developed and is commercializing novel implantable SNM devices for patients with urinary and bowel dysfunction. These conditions are caused by a miscommunication between the bladder and the brain and significantly impacts quality of life. Overactive bladder affects an estimated 87 million adults in the U.S. and Europe. Another estimated 40 million adults are reported to suffer from fecal incontinence/accidental bowel leakage. Axonics SNM therapy, which has been clinically proven to reduce symptoms and restore pelvic floor function, is now being offered at hundreds of medical centers across the U.S. and in dozens of select hospitals in Western Europe. Reimbursement coverage is well established in the U.S. and is a covered service in most European countries. The Axonics System is the first long-lived rechargeable SNM system approved for sale in the world, and the first to gain full-body MRI conditional labeling. For more information, visit www.axonics.com.
References:
1. Irwin DE, Kopp ZS, Agatep B, Milsom I, Abrams P. Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. BJU Int. 2011;108(7):1132-1138.
2. Pezzella A, McCrery R, Lane F, et al. Two-year outcomes of the ARTISAN-SNM study for the treatment of urinary urgency incontinence using the Axonics rechargeable sacral neuromodulation system [in press]. Neurourol Urodyn. 2021.
Dr. Lonnie T. Klein of Advanced Urology Institute in Safety Harbor, FL, designated as a UroLift® Center of Excellence
PLEASANTON, CALIF. (PRWEB) APRIL 27, 2021
NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced that Lonnie T. Klein, M.D., Advanced Urology Institute in Safety Harbor, FL, has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Klein has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.
Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.
“This designation recognizes Dr. Lonnie T. Klein as a UroLift Center of Excellence for his commitment to providing safe and effective treatment to patients with BPH,” said Dave Amerson, president of the Teleflex Interventional Urology business unit. “We are pleased to see the continued acceptance of the UroLift System as a standard of care treatment that may allow men to discontinue the use of BPH medications and improve their quality of life.”
Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.
Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.
About the UroLift® System
The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at www.UroLift.com.
About NeoTract | Teleflex Interventional Urology
A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.NeoTract.com.
About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit http://www.teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift® and Weck® – trusted brands united by a common sense of purpose
For Teleflex Incorporated:
Jake Elguicze, 610.948.2836
Treasurer and Vice President, Investor Relations
Media:
Nicole Osmer, 650.454.0504 nicole@healthandcommerce.com
*No instances of new, sustained erectile or ejaculatory dysfunction
1. Roehrborn, J Urology 2013 LIFT Study
2.McVary, J Sex Med 2016
MAC00968-01 Rev A
Advanced Urology Institute Recognized as an Axonics® Center of Excellence
Dr. Carole Gordon is an expert at treating bladder and bowel dysfunction with innovative Axonics Therapy
April 20, 2021
Advanced Urology Institute has been designated an Axonics Center of Excellence by Axonics Modulation Technologies, Inc. The designation recognizes the AUI team and Dr. Carole Gordon for her expertise with Axonics Therapy and sincere commitment to changing the lives of patients suffering from bladder and bowel dysfunction.
Today, millions of Americans suffer from overactive bladder and fecal incontinence.1 Patients in the Villages, Leesburg, and Ocala areas with chronic and debilitating symptoms related to bladder and bowel dysfunction may seek treatment from the experts at AUI. Axonics Therapy gently stimulates the sacral nerve (sacra neuromodulation), restoring normal communication between the brain and the bladder. Axonics Therapy has been clinically proven to provide rapid and long-lasting relief of symptoms associated with bladder and bowel dysfunction.
In a clinical study, 129 patients with urgency incontinence were treated with Axonics Therapy At 2-years, 93% of patients had successful therapy and 94% of patients were satisfied with theirtherapy.2
The Axonics Center of Excellence program recognizes highly trained and experienced physicians (typically urologists, urogynecologists, and colorectal surgeons) and clinical practices that are committed to patient education and providing exemplary care to achieve optimal clinical outcomes and patient satisfaction.
“AUI is proud to be recognized as a Center of Excellence. This designation is a testament to the dedication of our entire team, and in particular to Dr. Carole Gordon,” said Gina Barnes, Chief Administrative Officer. “We are committed to providing the best care to our patients and are extremely pleased to offer Axonics Therapy.”
About Advanced Urology Institute
As one of the largest full-service urology groups Florida, our 37 locations offer comprehensive urology services, from evaluation and pre-surgical preparation to surgery and rehabilitation. We have evaluated numerous patients and performed thousands of urologic surgical and cancer procedures in the last decade with excellent outcomes. We are dedicated to combining clinical excellence, advanced technology, and patient-centered care.
For more information contact AUI at: 855-977-4888
About Axonics Modulation Technologies, Inc. and Sacral Neuromodulation
Axonics, based in Irvine, Calif., has developed and is commercializing novel implantable SNM devices for patients with urinary and bowel dysfunction. These conditions are caused by a miscommunication between the bladder and the brain and significantly impacts quality of life.
Overactive bladder affects an estimated 87 million adults in the U.S. and Europe. Another estimated 40 million adults are reported to suffer from fecal incontinence/accidental bowel leakage. Axonics SNM therapy, which has been clinically proven to reduce symptoms and restore pelvic floor function, is now being offered at hundreds of medical centers across the U.S. and in dozens of select hospitals in Western Europe. Reimbursement coverage is well established in the U.S. and is a covered service in most European countries. The Axonics System is the first long-lived rechargeable SNM system approved for sale in the world, and the first to gain full-body MRI conditional labeling. For more information, visit www.axonics.com.
References: 1. Irwin DE, Kopp ZS, Agatep B, Milsom I, Abrams P. Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. BJU Int. 2011;108(7):1132-1138. 2. Pezzella A, McCrery R, Lane F, et al. Two-year outcomes of the ARTISAN-SNM study for the treatment of urinary urgency incontinence using the Axonics rechargeable sacral neuromodulation system [in press]. Neurourol Urodyn. 2021.
Advanced Urology Institute Names Scott B. Sellinger, MD as AUI President
PRESS RELEASE
FOR IMMEDIATE RELEASE
October 30, 2020
PRESS CONTACT:
NAME: Miriam Williams, CAO
PHONE: (850) 348-2944
EMAIL: miriam.williams@auihealth.com
ADVANCED UROLOGY INSTITUTE NAMES SCOTT B. SELLINGER, MD AS AUI PRESIDENT
Michael S. Grable, MD will step down at the end of 2020
OXFORD, FL, October 30, 2020 — Advanced Urology Institute is proud to announce that Dr. Scott B. Sellinger will become president in 2021.
He brings a wealth of experience and accomplishments to the position. Raised in upstate New York, Dr. Sellinger graduated from Syracuse University in 1982 with a Bachelor of Science degree in chemistry. After moving to Gainesville, he attended the University of Florida School of Medicine and graduated with honors in 1986.He completed his surgical internship and urological residency at UF. In 1987, he was named as Surgical Intern of the Year and in 1989 received the prestigious Harris Award for the outstanding urology resident.
He replaces Dr. Michael S. Grable, who is transitioning out of his role at the end of 2020 to spend more time away from the practice. Dr. Grable became president of Advanced Urology Institute in 2013 during the formative stages of the practice. His vision and leadership skills helped transform AUI into the successfully and highly respected practice it is today.
The AUI board of directors unanimously voted Dr. Sellinger as his replacement.
“It is my honor and privilege to serve as your next AUI president effective January 1, 2021,” says Dr. Sellinger. “Please help me thank Dr. Mike Grable for his six plus years of service as president of our organization. Under his strong guidance and leadership, AUI has become one of the largest independent urology groups in the country. I look forward to many more years of growth and prosperity, and most importantly, standing tall on our commitment to world-class, patient-centered care.”
Dr. Sellinger was president of Capital Medical Society in 2003 and served as president of the Florida Urological Society in 2005. He is past president of the Southeastern Section of the American Urological Association and is immediate past president of the American Association of Clinical Urologists (AACU). In addition, he has served on the board of directors for the Large Urology Group Practice Association (LUPGA) for the past six years. Dr. Sellinger has developed a special interest in risk management and prevention of medical errors and has lectured extensively on these subject matters during the past several years.
“Dr. Grable has kept our AUI organization consistently focused on our AUI mission of patient-centered care throughout his presidency, which has been the linchpin of our success,” says AUI CEO Richard Wooten. “I am certain that Dr. Sellinger will continue to guide our AUI organization to greater heights. We welcome Dr. Sellinger as our second AUI president.”
About Advanced Urology Institute:
Headquartered in Oxford, FL, Advanced Urology Institute (AUI) is a professional corporation of medical doctors (M.D.’s) who are board-certified and qualified in the surgical sub-specialty of urology. In addition to Oxford, AUI specialists are located throughout Florida in Ocala, Panama City, Tallahassee, Daytona Beach, St. Petersburg, Clearwater, Fort Meyers, and Naples. AUI was founded in 2014 as a single-specialty, physician led organization to respond more efficiently and effectively to the ever-mounting changes in healthcare and government regulations. This allows AUI to provide and dedicate the highest level in patient-centered care with over 600 providers, clinical and front office staff. Learn more at https://www.advancedurologyinstitute.com/